Novavax Says Company Is Aligned With Activist Investor on Measures Including Major Cost Cuts

Dow Jones
2025/04/29

By Roshan Fernandez

Novavax said the company is aligned with activist investor Shah Capital on a variety of initiatives, which include significant cost reductions and company reshaping.

Shah Capital holds approximately 7% of Novavax shares and pledged formal support for the Gaithersburg, Md.-based biotechnology company's board of directors. Novavax was previously under pressure after the investment firm felt Covid-19 sales were falling short.

The company said it continues to advance its growth strategy, and it appreciated collaborative input from both Shah and other long-term investors.

"We have always welcomed the beneficial perspectives of all our shareholders and appreciate the shared belief in the tremendous promise of Novavax's technology and the value it can bring to the healthcare landscape globally," the company said in a statement.

Write to Roshan Fernandez at roshan.fernandez@wsj.com

(END) Dow Jones Newswires

April 28, 2025 18:04 ET (22:04 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10